Keywords: fda, approvable, letter, novantrone, ms, immunex, corp

FDA approvable letter for Novantrone in MS

Article | 03 March 2000

Print This

Immunex Corp has received an approvable letter from the US Food and DrugAdministration for its anticancer agent Novantrone (mitoxantrone for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in